Silence Therapeutics gets patent for siRNA delivery; Drug delivery has impact on patient compliance;

> Silence Therapeutics awarded a patent for its siRNA delivery system, called AtuPLEX. More here

> Nano lipid carriers "are a smarter generation of drug delivery carriers for lovastatin." Abstract

> Report says drug-delivery innovations matter when it comes to patient compliance. Release

> Gold nanoshells are getting ready to leave the lab and, possibly, "change the way we think about drug delivery." Blog post

Drug delivery patent of the week: Cancer cell diagnosis by targeting delivery of nanodevices. Patent

And Finally... A "talking" epinephrine delivery device, e-cue by Intelliject, has received tentative FDA approval, but will it give a verbal "cease-and-desist" due to litigation over the tech? The story

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.